Clinical trial
A Study of Valacyclovir to Suppress HSV and HIV Shedding in Coinfected Persons
NCT00161434 · University of Washington, Other · Completed
Key facts
| NCT number | NCT00161434 |
|---|---|
| Title | A Study of Valacyclovir to Suppress HSV and HIV Shedding in Coinfected Persons |
| Official title | A Randomized, Double-Blind, Placebo Controlled Crossover Trial Using Valacyclovir to Suppress HSV and HIV Shedding in HIV-1, HSV-2 Coinfected Persons |
| Lead sponsor | University of Washington, Other |
| Collaborators | GlaxoSmithKline Industry National Institutes of Health (NIH) NIH |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Herpes Simplex, HIV Infections |
| Intervention type | Drug |
| Interventions | valacyclovir, placebo |
| Enrollment | 60 |
| Start date | Mar 1, 2003 |
| Primary completion | Jun 1, 2006 |
| Completion | Jun 1, 2006 |
| First posted | Sep 12, 2005 |
| Last update posted | Jan 10, 2008 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: